Business
PAVmed Closes Preferred Stock and Senior Secured Note Financings, Eliminating All Previously Outstanding Convertible Securities
PAVmed Inc. (Nasdaq: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today announced the closing of preferred stock and senior secured note financings by existing long-term investors, resulting in the elimination of a significant legacy capital structure overhang from previously outstanding convertible securities and a materially strengthened balance sheet.
About this update from Lucid Diagnostics Inc.
[{"type":"text","content":"Series D Preferred Stock offering yielded $30 million of gross proceeds and includes warrants exercisable for up to an additional $30 million upon publication of a positive draft EsoGuard Medicare local coverage determination","length":225,"tagName":"p","attribs":{}},{"type":"text","content":"Series D Preferred Stock convertible into common stock subject to stockholder approval at an upcoming special meeting","length":117,"tagName":"p","attribs":{}},{"type":"text","content":"New senior secured note with three-year maturity yielded an additional $15 million of gross proceeds","length":100,"tagName":"p","attribs":{}},{"type":"text","content":"Proceeds used to redeem and retire all previously outstanding convertible securities, eliminating a significant legacy capital structure overhang ","length":145,"tagName":"p","attribs":{}},{"type":"text","content":"Transactions yielded approximately $7.7 million in net cash proceeds, materially strengthening the Company's balance sheet","length":126,"tagName":"p","attribs":{}},{"type":"text","content":"NEW YORK, Feb. 4, 2026 /PRNewswire/ -- PAVmed Inc. (Nasdaq: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today announced the closing of preferred stock and senior secured note financings by existing long-term investors, resulting in the elimination of a significant legacy capital structure overhang from previously outstanding convertible securities and a materially strengthened balance sheet.","length":543,"tagName":"p"},{"type":"image","alt":"PAVmed Inc. is a diversified commercial-stage medical technology company operating in the medical device, diagnostics, and digital health sectors. (PRNewsfoto/PAVmed Inc.)","displaySize":"","headline":null,"caption":"PAVmed Inc. is a diversified commercial-stage medical technology company operating in the medical device, diagnostics, and digital health sectors. (PRNewsfoto/PAVmed Inc.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":81,"url":"https://media.zenfs.com/en/prnewswire.com/b33818e0ad32f6b512ca93166f23ff80"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/_9ksw7DB5omdDmUMhUY16g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTE0MztjZj13ZWJw/https://media.zenfs.com/en/p...